Mushrooms Inc. (OTC: MSRM) today announced its newly formed business development team, strategically assembled to harness the momentum generated by the company’s new technology and Innovation lab development. The team is comprised of accomplished professionals with diverse backgrounds and poised to drive Mushrooms Inc. into a new era of innovation and growth. “This enhanced business development team represents a pivotal milestone for Mushrooms Inc.,” said Donald Steinberg, board director of Mushrooms Inc. “As we make strides in the mushroom sector, our team’s collective experience and expertise provide a robust foundation for innovation and growth.”
To view the full press release, visit https://ibn.fm/FatXj
About Mushrooms Inc.
Mushrooms is a publicly traded company on the OTC Markets with the stock symbol MSRM. The vision for the company is to support the growth of the mushroom industry through collaboration, innovation and development. Creating and supporting environmentally beneficial product innovation is at the heart of Mushrooms. Its current focus is on the industrial application of mycelium for the creation of carbon-neutral products for the building and health care industries as well as creating supplements based on the proven health benefits of mushrooms. Research and development is the path to achieving great innovation, and the pioneers are the ones the company looks to for fortitude and enduring dedication to the world of mycology. The working relationships it fosters will result in scientifically proven products that advance the health of body, mind and environment. For more information about the company, visit www.MushroomsInc.com.
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.psychedelicnewswire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
